Overview

Tight Hemodynamic Control in Patients Who Are Chronically on Metoprolol

Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study proposes to assess the effect of the standard of care, which is continuation of the pre op beta blocker dose into the post operative period compared to the administration of esmolol titrated to a pre determined target HR. The primary outcome will compare postoperative plasma levels of metoprolol in 2 cohorts in a group who has been continued on metoprolol (administrated via a nasogastric tube in NPO patients) to a group who has been withdrawn from metoprolol but given an esmolol infusion titrated to HR. Secondary outcomes will compare a) the hemodynamic responses, documenting the incidence of unplanned hypotension and bradycardia and b) to compare the effects of Heart rate to the incidence of myocardial ischemia, arrhythmias, delirium and infarction.
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Baxter Healthcare Corporation
Treatments:
Esmolol
Metoprolol